Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology - Seite 2

Nachrichtenquelle: IRW Press
26.10.2020, 08:03  |  503   |   |   

 

 

About the Journal of Cosmetic Dermatology

 

The Journal of Cosmetic Dermatology is the official journal of the International Academy of Cosmetic Dermatology (IACD) and the Canadian Association of Aesthetic Medicine (CAAM). The Journal publishes high quality, peer-reviewed articles on all aspects of cosmetic dermatology with the aim to foster the highest standards of patient care in cosmetic dermatology. Published quarterly, the Journal of Cosmetic Dermatology facilitates continuing professional development and provides a forum for the exchange of scientific research and innovative techniques.

 

For more information about the Journal of Cosmetic Dermatology, please visit: https://onlinelibrary.wiley.com/page/journal/14732165/homepage/product ...

 

About Sirona Biochem Corp.

 

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

 

Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.

 

For more information regarding this press release, please contact:

 

Investor Enquiries:

 

Jonathan Williams

Managing Director

Momentum PR

Canada

Phone:  1.450.332.6939

Email: jwilliams@momentumpr.com 

 

Marcus Kaemper

Germany

Phone: +49 160 920 340 25

Email: mk@sironabiochem.com

 

Corporate Enquiries:

 

Dr. Howard Verrico

CEO, Chairman of the Board

Sirona Biochem Corp.

Phone:  1.604.641.4466

Email: info@sironabiochem.com

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Seite 2 von 3
Sirona Biochem Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

Diskussion: Sirona Biochem
Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology - Seite 2 Vancouver, Canada – October 26, 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that the clinical study using .2% TFC-1067 and conducted by Dr. Zoe Draelos of Dermatology Consulting Services, …

Nachrichten des Autors

Titel
Titel
Titel
Titel

COMMUNITY

ZeitTitel
21:43 Uhr